7th Aug 2023 10:27
Ondine Biomedical Inc - Vancouver-based life sciences company specialising in photodisinfection therapies - Partners with Kelowna General Hospital in Canada for a pilot program to prevent hospital-acquired infections using its Steriwave nasal photodisinfection therapy. Says Steriwave is already in use at a number of hospitals acrsoss Canada.
Chief Executive Officer Carolyn Cross says: "We believe that every patient deserves the best protection against HAIs. By wiping out the pathogens in the nose, which is a major reservoir for these potentially fatal pathogens, our photodisinfection treatment can reduce HAIs following major surgeries by up to 80%."
Current stock price: 16.23 pence, up 1.4% on Monday
12-month change: down 58%
By Sabrina Penty, Alliance News reporter
Comments and questions to [email protected]
Copyright 2023 Alliance News Ltd. All Rights Reserved.
Related Shares:
Ondine Biomed